Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FSMD | 41.01 | 0.34 | +0.84% |
| Fidelity Small-Mid Multifactor ETF | |||
| LQDB | 84.70 | N/A | N/A |
| iShares BBB Rated Corporate Bond ETF | |||
| ISHG | 74.48 | -0.28 | -0.37% |
| iShares 1-3 Year International TrsBd ETF | |||
| EPU | 48.59 | -0.20 | -0.42% |
| iShares MSCI Peru ETF | |||
| SZK | 11.79 | -0.08 | -0.70% |
| ProShares UltraShort Consumer Staples | |||
A.I.dvisor tells us that INNMF and BIVI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and BIVI's prices will move in lockstep.
| Ticker / NAME | Correlation To INNMF | 1D Price Change % | ||
|---|---|---|---|---|
| INNMF | 100% | -10.49% | ||
| BIVI - INNMF | 26% Poorly correlated | -0.92% | ||
| HOFBF - INNMF | 23% Poorly correlated | N/A | ||
| CYTK - INNMF | 23% Poorly correlated | +0.69% | ||
| PHRRF - INNMF | 20% Poorly correlated | +3.27% | ||
| IVEVF - INNMF | 15% Poorly correlated | N/A | ||
More | ||||